康复新液联合消化内镜治疗急性上消化道出血

Treatment of Acute Upper Gastrointestinal Hemorrhage With Concomitant Gastroenteroscopy

目的分析急性上消化道出血患者采用康复新液联合消化内镜治疗的临床疗效。方法将2017年1月-2019年8月在本院接受治疗的42例急性上消化道出血患者纳入本次研究,根据不同的止血方法进行分组:对照组(n=21)采用消化内镜治疗;观察组(n=21)采用康复新液联合消化内镜治疗,比较治疗效果。结果 (1)临床疗效:观察组中,显效13例、有效7例、无效1例,总有效率95.24%;对照组中,显效9例、有效9例、无效3例,总有效率85.71%,差异不具有统计学意义(P> 0.05)。(2)并发症发生率:观察组出现再出血1例、发热1例,发生率9.52%;对照组中,再出血3例、发热3例、穿孔2例,发生率38.10%。差异具有统计学意义(P <0.05)。差异具有统计学意义(P <0.05)。结论康复新液联合消化内镜治疗在急性上消化道出血的治疗中具有良好的应用效果,适合在临床中应用。

Objective To analyze the clinical effect of Kangfuxin combined with digestive endoscopy in the treatment of acute upper gastrointestinal bleeding. Methods 42 patients with acute upper gastrointestinal bleeding treated in our hospital from January 2017 to August 2019 were included in this study. They were divided into two groups according to different hemostasis methods: control group(n=21) was treated with digestive endoscopy;observation group(n=21) was treated with Kangfuxin combined with digestive endoscopy. Results (1) Clinical efficacy: In the observation group, 13 cases were markedly effective, 7 cases were effective and 1 case was ineffective, the total effective rate was 95.24%. In the control group, 9 cases were markedly effective, 9 cases were effective and 3 cases were ineffective, the total effective rate was 85.71%. The difference was not statistically significant(P > 0.05).(2) Incidence of complications: 1 case of re-bleeding and 1 case of fever occurred in the observation group(9.52%);in the control group, there were 3 cases of rebleeding, 3 cases of fever and 2 case of perforation, with an incidence rate of 38.10%. The difference was statistically significant(P < 0.05). Conclusion Kangfuxin combined with digestive endoscopy has a good application effect in the treatment of acute upper gastrointestinal bleeding, which is suitable for clinical application.